1. Home
  2. ORMP vs VTGN Comparison

ORMP vs VTGN Comparison

Compare ORMP & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORMP
  • VTGN
  • Stock Information
  • Founded
  • ORMP 2002
  • VTGN 1998
  • Country
  • ORMP United States
  • VTGN United States
  • Employees
  • ORMP N/A
  • VTGN N/A
  • Industry
  • ORMP Biotechnology: Pharmaceutical Preparations
  • VTGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORMP Health Care
  • VTGN Health Care
  • Exchange
  • ORMP Nasdaq
  • VTGN Nasdaq
  • Market Cap
  • ORMP N/A
  • VTGN 59.8M
  • IPO Year
  • ORMP N/A
  • VTGN N/A
  • Fundamental
  • Price
  • ORMP $2.15
  • VTGN $2.38
  • Analyst Decision
  • ORMP Hold
  • VTGN
  • Analyst Count
  • ORMP 1
  • VTGN 0
  • Target Price
  • ORMP N/A
  • VTGN N/A
  • AVG Volume (30 Days)
  • ORMP 63.0K
  • VTGN 306.2K
  • Earning Date
  • ORMP 08-15-2025
  • VTGN 08-12-2025
  • Dividend Yield
  • ORMP N/A
  • VTGN N/A
  • EPS Growth
  • ORMP N/A
  • VTGN N/A
  • EPS
  • ORMP N/A
  • VTGN N/A
  • Revenue
  • ORMP $2,000,000.00
  • VTGN $486,000.00
  • Revenue This Year
  • ORMP N/A
  • VTGN N/A
  • Revenue Next Year
  • ORMP N/A
  • VTGN $943.32
  • P/E Ratio
  • ORMP N/A
  • VTGN N/A
  • Revenue Growth
  • ORMP 196.74
  • VTGN N/A
  • 52 Week Low
  • ORMP $1.82
  • VTGN $1.90
  • 52 Week High
  • ORMP $3.09
  • VTGN $4.21
  • Technical
  • Relative Strength Index (RSI)
  • ORMP 46.79
  • VTGN 55.71
  • Support Level
  • ORMP $2.09
  • VTGN $1.99
  • Resistance Level
  • ORMP $2.20
  • VTGN $2.63
  • Average True Range (ATR)
  • ORMP 0.09
  • VTGN 0.15
  • MACD
  • ORMP -0.00
  • VTGN 0.05
  • Stochastic Oscillator
  • ORMP 36.84
  • VTGN 60.87

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Share on Social Networks: